From Enrollment to Final Visit
Data from clinical trials are used by the Food and Drug Administration (FDA) to determine approval of an investigational drug or device for market. It is paramount to safely marketing the drug that all data collected are accurate and complete. The FDA has regulations that clearly define how data should be collected, documented, and managed. Good clinical practices (GCPs) also provide guidance on conducting study visits and collecting data.